Trials / Completed
CompletedNCT02049567
Clinical Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL)
Clinical Evaluation of the FluidVision Accommodating Intraocular Lens
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 170 (actual)
- Sponsor
- PowerVision · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of an investigational IOL.
Detailed description
Eligible subjects will receive the investigational IOL in one eye and be followed at 1 day, 1 week, 1 month, 3 months, 6 months, 12 months, 18 months, 24 months and 36 months post-operation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FluidVision AIOL | Investigational implantable medical device intended for long-term use over the lifetime of the cataract subject |
| PROCEDURE | Cataract Surgery | Performed using standard microsurgical techniques |
Timeline
- Start date
- 2014-01-14
- Primary completion
- 2015-06-24
- Completion
- 2017-11-06
- First posted
- 2014-01-30
- Last updated
- 2021-05-21
Locations
8 sites across 2 countries: Germany, South Africa
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02049567. Inclusion in this directory is not an endorsement.